MedTrace Logo

Coronary Laser Atherectomy Registry From an International Taskforce

NCT07348341 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-01-16

No results posted yet for this study

Summary

This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).

Conditions

  • Stable Coronary Artery Disease
  • Acute Coronary Syndromes

Interventions

DEVICE

Excimer Laser Coronary Atherectomy (ELCA)

ELCA treat a significant coronary stenosis or recanalize occluded coronary arteries using UV during percutaneous coronary intervention.

Sponsors & Collaborators

  • Philips Medical Systems

    collaborator INDUSTRY

  • European Cardiovascular Research Center

    collaborator NETWORK

  • Ceric Sàrl

    lead INDUSTRY

Principal Investigators

  • Peter O'kane, Professor · Dorset Heart Centre, The Royal Bournemouth Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2028-07-30
Completion
2029-07-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07348341 on ClinicalTrials.gov